Wyeth Vaccines

Wyeth is one of a small number of pharmaceutical companies that discovers and develops vaccines. Vaccines traditionally have been targeted to preventing disease or "treating the healthy." Our vaccines R&D efforts, while centered on prevention, also seek to determine whether certain vaccine candidates might have utility in treating disease.

Current topics of R&D interest include bacteria such as pneumococcus, meningococcus, and group A streptococcus. Wyeth Vaccines R&D also targets viruses such as the human immunodeficiency virus (HIV) and papilloma virus.

Wyeth is unique in that we have significant marketed products across all three discovery and development platforms—small molecules, biopharmaceuticals, and vaccines. Our discovery and development efforts parallel this. One important example is the involvement of Wyeth Vaccines R&D in the search for both active and passive immunotherapies for Alzheimer's disease. Teamed with scientists from Wyeth's small molecule and biopharmaceuticals programs, Wyeth hopes to be able to bring forward successful treatments to combat Alzheimer's disease.

Wyeth Vaccines R&D activities are carried out in facilities in Research Triangle Park, NC; Sanford, NC; Pearl River, NY; and Grange Castle, Ireland.

228286-01